- call +1-201-465-4211
- email sales@mrinsights.biz
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Scope of the Report:
This report studies the Personalized Medicines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Personalized Medicines market by product type and applications/end industries.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
The global Personalized Medicines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Personalized Medicines.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Market Segment by Applications, can be divided into
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Personalized Medicines Market Overview
1.1 Product Overview and Scope of Personalized Medicines
1.2 Classification of Personalized Medicines by Types
1.2.1 Global Personalized Medicines Revenue Comparison by Types (2017-2023)
1.2.2 Global Personalized Medicines Revenue Market Share by Types in 2017
1.2.3 PM Diagnostics
1.2.4 PM Therapeutics
1.2.5 Personalized Medical Care
1.2.6 Personalized Nutrition & Wellness
1.3 Global Personalized Medicines Market by Application
1.3.1 Global Personalized Medicines Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Dietary Care Centers
1.3.5 Others
1.4 Global Personalized Medicines Market by Regions
1.4.1 Global Personalized Medicines Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Personalized Medicines Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Personalized Medicines Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Personalized Medicines Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Personalized Medicines Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Personalized Medicines Status and Prospect (2013-2023)
1.5 Global Market Size of Personalized Medicines (2013-2023)
2 Manufacturers Profiles
2.1 3G Biotech
2.1.1 Business Overview
2.1.2 Personalized Medicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 3G Biotech Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.2 Quest Diagnostics
2.2.1 Business Overview
2.2.2 Personalized Medicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Quest Diagnostics Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Laboratory Corporation of America
2.3.1 Business Overview
2.3.2 Personalized Medicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Laboratory Corporation of America Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott
2.4.1 Business Overview
2.4.2 Personalized Medicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.5 Agendia NV
2.5.1 Business Overview
2.5.2 Personalized Medicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Agendia NV Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.6 Asuragen Inc
2.6.1 Business Overview
2.6.2 Personalized Medicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Asuragen Inc Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Becton Dickinson
2.7.1 Business Overview
2.7.2 Personalized Medicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Becton Dickinson Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.8 CardioDx Inc.
2.8.1 Business Overview
2.8.2 Personalized Medicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CardioDx Inc. Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.9 Foundation Medicine
2.9.1 Business Overview
2.9.2 Personalized Medicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Foundation Medicine Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.10 Qiagen
2.10.1 Business Overview
2.10.2 Personalized Medicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Qiagen Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.11 Siemens Healthcare
2.11.1 Business Overview
2.11.2 Personalized Medicines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Siemens Healthcare Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amgen
2.12.1 Business Overview
2.12.2 Personalized Medicines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Amgen Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bristol-Myers Squibb
2.13.1 Business Overview
2.13.2 Personalized Medicines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bristol-Myers Squibb Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.14 GE Healthcare
2.14.1 Business Overview
2.14.2 Personalized Medicines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GE Healthcare Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Personalized Medicines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pfizer Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.16 Sanofi
2.16.1 Business Overview
2.16.2 Personalized Medicines Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Sanofi Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.17 23andMe
2.17.1 Business Overview
2.17.2 Personalized Medicines Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 23andMe Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.18 Illumina
2.18.1 Business Overview
2.18.2 Personalized Medicines Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Illumina Personalized Medicines Revenue, Gross Margin and Market Share (2016-2017)
3 Global Personalized Medicines Market Competition, by Players
3.1 Global Personalized Medicines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Personalized Medicines Players Market Share
3.2.2 Top 10 Personalized Medicines Players Market Share
3.3 Market Competition Trend
4 Global Personalized Medicines Market Size by Regions
4.1 Global Personalized Medicines Revenue and Market Share by Regions
4.2 North America Personalized Medicines Revenue and Growth Rate (2013-2018)
4.3 Europe Personalized Medicines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Personalized Medicines Revenue and Growth Rate (2013-2018)
4.5 South America Personalized Medicines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Personalized Medicines Revenue and Growth Rate (2013-2018)
5 North America Personalized Medicines Revenue by Countries
5.1 North America Personalized Medicines Revenue by Countries (2013-2018)
5.2 USA Personalized Medicines Revenue and Growth Rate (2013-2018)
5.3 Canada Personalized Medicines Revenue and Growth Rate (2013-2018)
5.4 Mexico Personalized Medicines Revenue and Growth Rate (2013-2018)
6 Europe Personalized Medicines Revenue by Countries
6.1 Europe Personalized Medicines Revenue by Countries (2013-2018)
6.2 Germany Personalized Medicines Revenue and Growth Rate (2013-2018)
6.3 UK Personalized Medicines Revenue and Growth Rate (2013-2018)
6.4 France Personalized Medicines Revenue and Growth Rate (2013-2018)
6.5 Russia Personalized Medicines Revenue and Growth Rate (2013-2018)
6.6 Italy Personalized Medicines Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Personalized Medicines Revenue by Countries
7.1 Asia-Pacific Personalized Medicines Revenue by Countries (2013-2018)
7.2 China Personalized Medicines Revenue and Growth Rate (2013-2018)
7.3 Japan Personalized Medicines Revenue and Growth Rate (2013-2018)
7.4 Korea Personalized Medicines Revenue and Growth Rate (2013-2018)
7.5 India Personalized Medicines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Personalized Medicines Revenue and Growth Rate (2013-2018)
8 South America Personalized Medicines Revenue by Countries
8.1 South America Personalized Medicines Revenue by Countries (2013-2018)
8.2 Brazil Personalized Medicines Revenue and Growth Rate (2013-2018)
8.3 Argentina Personalized Medicines Revenue and Growth Rate (2013-2018)
8.4 Colombia Personalized Medicines Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Personalized Medicines by Countries
9.1 Middle East and Africa Personalized Medicines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Personalized Medicines Revenue and Growth Rate (2013-2018)
9.3 UAE Personalized Medicines Revenue and Growth Rate (2013-2018)
9.4 Egypt Personalized Medicines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Personalized Medicines Revenue and Growth Rate (2013-2018)
9.6 South Africa Personalized Medicines Revenue and Growth Rate (2013-2018)
10 Global Personalized Medicines Market Segment by Type
10.1 Global Personalized Medicines Revenue and Market Share by Type (2013-2018)
10.2 Global Personalized Medicines Market Forecast by Type (2018-2023)
10.3 PM Diagnostics Revenue Growth Rate (2013-2023)
10.4 PM Therapeutics Revenue Growth Rate (2013-2023)
10.5 Personalized Medical Care Revenue Growth Rate (2013-2023)
10.6 Personalized Nutrition & Wellness Revenue Growth Rate (2013-2023)
11 Global Personalized Medicines Market Segment by Application
11.1 Global Personalized Medicines Revenue Market Share by Application (2013-2018)
11.2 Personalized Medicines Market Forecast by Application (2018-2023)
11.3 Hospitals Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Dietary Care Centers Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global Personalized Medicines Market Size Forecast (2018-2023)
12.1 Global Personalized Medicines Market Size Forecast (2018-2023)
12.2 Global Personalized Medicines Market Forecast by Regions (2018-2023)
12.3 North America Personalized Medicines Revenue Market Forecast (2018-2023)
12.4 Europe Personalized Medicines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Personalized Medicines Revenue Market Forecast (2018-2023)
12.6 South America Personalized Medicines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Personalized Medicines Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Personalized Medicines Picture
Table Product Specifications of Personalized Medicines
Table Global Personalized Medicines and Revenue (Million USD) Market Split by P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
